Sign in

CIK 0001563880

  • Non-accelerated filer
  • Smaller reporting company

Trevi Therapeutics, Inc.

Sign in to watch
Ticker
TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450834299
Phone
+1 203-304-2499
Business address
195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
  1. 4 Open-market sale Chief Financial Officer sold 4,350 shares at $2.64 ($11,485)
  2. 4 Open-market sale President & CEO sold 25,037 shares at $2.86 ($71,576)
  3. 4 Open-market sale President & CEO sold 4,578 shares at $2.90 ($13,276)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale Chief Financial Officer sold 785 shares at $2.02 ($1,586)
  11. 4 Planned sale Chief Financial Officer sold 711 shares at $2.20 ($1,564)
  12. 4 Planned sale Chief Financial Officer sold 682 shares at $2.36 ($1,610)
  13. 4 Planned sale Chief Financial Officer sold 687 shares at $2.34 ($1,608)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Exercise or conversion Chief Commercial Officer acquired 6,250 shares (option exercise)

Page 4 of 13 · 257 filings